CUV has the only current approved if not only treatment for the skin disorder so it warrants a premium PE. How much, well Ill let individual investors determine that.
They also have the cash in the bank to rollout Scenesse in the US without having to search for funds so its lets hit the road full speed ahead. They were ready for this, so delays will be minimal.
- Forums
- ASX - By Stock
- CUV
- News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment
News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-56
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.83 |
Change
0.235(1.61%) |
Mkt cap ! $739.1M |
Open | High | Low | Value | Volume |
$14.76 | $14.96 | $14.46 | $961.6K | 65.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 105 | $14.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.83 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 55 | 14.830 |
3 | 219 | 14.820 |
8 | 350 | 14.810 |
7 | 522 | 14.800 |
3 | 190 | 14.790 |
Price($) | Vol. | No. |
---|---|---|
14.850 | 200 | 10 |
14.860 | 20 | 4 |
14.870 | 174 | 3 |
14.880 | 333 | 7 |
14.890 | 178 | 3 |
Last trade - 15.30pm 31/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online